Stephen B. Fox
Impact in
- Cancer Research top 0.05%
- Cancer, Hypoxia, and Metabolism
- Cancer Genomics and Diagnostics
- Breast Cancer Treatment Studies
- Oncology top 0.05%
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
- Lymphatic System and Diseases
Papers in
- Cancer Research 148
- Cancer Genomics and Diagnostics 55
- Cancer, Hypoxia, and Metabolism 45
- Breast Cancer Treatment Studies 43
-
- Angiogenesis and VEGF in Cancer 56
- Co-authors
- Adrian L. Harris (97 shared papers)Russell Leek (18 shared papers)Kevin C. Gatter (26 shared papers)Alexander Dobrovic (35 shared papers)Roy Bicknell (12 shared papers)Helen Turley (22 shared papers)Alison H. Banham (12 shared papers)R Whitehouse (8 shared papers)
- Journals
- Journal of Clinical Oncology (27 papers)The Journal of Pathology (23 papers)Breast Cancer Research and Treatment (20 papers)Histopathology (19 papers)British Journal of Cancer (19 papers)
- Partner nations
- AustraliaUnited KingdomUnited States
In The Last Decade
Stephen B. Fox
405 papers receiving 25.8k citations
Stephen B. Fox's Hit Papers
Peers
Comparison fields: 5 of 185
- Cancer Research 7.0k
- Oncology 9.6k
- Otorhinolaryngology 663
- Molecular Biology 10.4k
- Reproductive Medicine 987
Countries citing papers authored by Stephen B. Fox
This map shows the geographic impact of Stephen B. Fox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen B. Fox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen B. Fox more than expected).
Fields of papers citing papers by Stephen B. Fox
This network shows the impact of papers produced by Stephen B. Fox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen B. Fox. The network helps show where Stephen B. Fox may publish in the future.
Co-authors
The 25 scholars most cited alongside Stephen B. Fox, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 415 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers Hit paper breakdown → | 2009 | 1055 |
| 2 | Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome Hit paper breakdown → | 2008 | 1048 |
| 3 | Quantification of Regulatory T Cells Enables the Identification of High-Risk Breast Cancer Patients and Those at Risk of Late Relapse Hit paper breakdown → | 2006 | 926 |
| 4 | BRCA Mutation Frequency and Patterns of Treatment Response in BRCA Mutation–Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group Hit paper breakdown → | 2012 | 868 |
| 5 | Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor beta-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis. Hit paper breakdown → | 1997 | 700 |
| 6 | Breast cancer prognostic classification in the molecular era: the role of histological grade Hit paper breakdown → | 2010 | 666 |
| 7 | Lymphangiogenesis and lymphatic vessel remodelling in cancer Hit paper breakdown → | 2014 | 633 |
| 8 | Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation Hit paper breakdown → | 1996 | 631 |
| 9 | Prognostic Significance of p16 INK4A and Human Papillomavirus in Patients With Oropharyngeal Cancer Treated on TROG 02.02 Phase III Trial Hit paper breakdown → | 2010 | 576 |
| 10 | The 2019 World Health Organization classification of tumours of the breast Hit paper breakdown → | 2020 | 573 |
| 11 | Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists Hit paper breakdown → | 2010 | 510 |
| 12 | 2002 | 385 | |
| 13 | 1995 | 374 | |
| 14 | 2011 | 353 | |
| 15 | 1995 | 351 | |
| 16 | Normal human tissues, in addition to some tumors, express multiple different CD44 isoforms. | 1994 | 275 |
| 17 | Non-small-cell lung carcinoma tumor growth without morphological evidence of neo-angiogenesis. | 1997 | 264 |
| 18 | 2011 | 256 | |
| 19 | 2008 | 229 | |
| 20 | 2012 | 229 |
About Stephen B. Fox
Stephen B. Fox is a scholar working on Cancer Research, Molecular Biology, Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 415 papers that have together received 26.2k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (56 papers), Cancer Genomics and Diagnostics (55 papers), Cancer, Hypoxia, and Metabolism (45 papers), Breast Cancer Treatment Studies (43 papers), HER2/EGFR in Cancer Research (25 papers), Genetic factors in colorectal cancer (25 papers), Lung Cancer Treatments and Mutations (24 papers) and Cancer Immunotherapy and Biomarkers (19 papers). The work is most often cited by research in Cancer Research (7.0k citations), Oncology (9.6k citations), Otorhinolaryngology (663 citations), Molecular Biology (10.4k citations) and Reproductive Medicine (987 citations). Stephen B. Fox has collaborated with scholars based in Australia, United Kingdom and United States. Frequent co-authors include Adrian L. Harris, Russell Leek, Kevin C. Gatter, Alexander Dobrovic, Roy Bicknell, Helen Turley, Alison H. Banham, R Whitehouse, Gaynor J. Bates and David D.L. Bowtell. Their work appears in journals such as Journal of Clinical Oncology, The Journal of Pathology, Breast Cancer Research and Treatment, Histopathology and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.